drugset / Trial / NCT02002247

SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).

NCT02002247

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the investigators' research program is to investigate the effects of perioperative high dose selenium supplementation in high-risk cardiac surgical patients undergoing complicated open heart surgery. The investigators hypothesize that the therapeutic strategy tested in this randomized trial may contribute to a fewer complications, less organ injury and fewer deaths. Before the investigators conducted the large definitive trial, they conducted a pilot study to assess the feasibility of the protocol, and are rolling the pilot patients into the definitive trial.

Timeline

Start
2015-01
Primary completion
2021-02
Completion
2021-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium selenite Unknown 1000 ug Intravenous

Indications